Pfizer clinches deal for obesity drug developer Metsea after a bidding war with Novo Nordisk

by | Nov 8, 2025 | news, Top News

Spread the love
NEW YORK (AP) — U.S. pharmaceutical giant Pfizer signed a deal to purchase development-stage obesity drugmaker Metsera Inc., winning a bidding war against Novo Nordisk, the Danish drugmaker behind weight-loss treatments Ozempic and Wegovy.

Written By

Written by Albert Pham, News Curator and Blogger

Related Posts

0 Comments